Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Avogaro

Showing results (271-280 of 426) with videos related to

Pageof 43
Sort By:
The Journal of Clinical Endocrinology and Metabolism|January 5, 2018
Effects of Hypoglycemia on Circulating Stem and Progenitor Cells in Diabetic PatientsGian Paolo Fadini, Federico Boscari, Roberta Cappellari, et al.
European Heart Journal|June 27, 2015
Risk of hospitalization for heart failure in patients with type 2 diabetes newly treated with DPP-4 inhibitors or other oral glucose-lowering medications: a retrospective registry study on 127,555 patients from the Nationwide OsMed Health-DB DatabaseGian Paolo Fadini, Angelo Avogaro, Luca Degli Esposti, et al.
Obesity (Silver Spring, Md.)|December 26, 2006
A visfatin promoter polymorphism is associated with low-grade inflammation and type 2 diabetesYuan-Yuan Zhang, Lucia Gottardo, Ryan Thompson, et al.
Diabetes, Obesity & Metabolism|July 22, 2020
Exposure to dipeptidyl-peptidase 4 inhibitors and the risk of pneumonia among people with type 2 diabetes: Retrospective cohort study and meta-analysisMario Luca Morieri, Benedetta Maria Bonora, Enrico Longato, et al.
Endocrinology|August 6, 2014
Uncarboxylated osteocalcin stimulates 25-hydroxy vitamin D production in Leydig cell line through a GPRC6a-dependent pathwayLuca De Toni, Vincenzo De Filippis, Simone Tescari, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|February 17, 2021
Comparing the accuracy of transcutaneous sensor and 90-day implantable glucose sensorFederico Boscari, Martina Vettoretti, Anna Maria Letizia Amato, et al.
Journal of Diabetes and Its Complications|May 29, 2017
A decade-long telemedicine screening program for diabetic retinopathy in the north-east of ItalyStela Vujosevic, Porzia Pucci, Margherita Casciano, et al.
Diabetes Care|April 2, 2010
The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alphaGian Paolo Fadini, Elisa Boscaro, Mattia Albiero, et al.
Diabetes Care|February 13, 2010
Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetesGian Paolo Fadini, Elisa Boscaro, Saula de Kreutzenberg, et al.
Aging Clinical and Experimental Research|April 4, 2003
The fatty acid composition of plasma phospholipids and the insulin sensitivity in elderly diabetic patients. The Pro.V.A. studyEnzo Manzato, Giovanni Roselli della Rovere, Angelo Avogaro, et al.
Pageof 43

Showing results (271-280 of 426) with videos related to

Sort By:
Pageof 43
The Journal of Clinical Endocrinology and Metabolism|January 5, 2018
Effects of Hypoglycemia on Circulating Stem and Progenitor Cells in Diabetic PatientsGian Paolo Fadini, Federico Boscari, Roberta Cappellari, et al.
European Heart Journal|June 27, 2015
Risk of hospitalization for heart failure in patients with type 2 diabetes newly treated with DPP-4 inhibitors or other oral glucose-lowering medications: a retrospective registry study on 127,555 patients from the Nationwide OsMed Health-DB DatabaseGian Paolo Fadini, Angelo Avogaro, Luca Degli Esposti, et al.
Obesity (Silver Spring, Md.)|December 26, 2006
A visfatin promoter polymorphism is associated with low-grade inflammation and type 2 diabetesYuan-Yuan Zhang, Lucia Gottardo, Ryan Thompson, et al.
Diabetes, Obesity & Metabolism|July 22, 2020
Exposure to dipeptidyl-peptidase 4 inhibitors and the risk of pneumonia among people with type 2 diabetes: Retrospective cohort study and meta-analysisMario Luca Morieri, Benedetta Maria Bonora, Enrico Longato, et al.
Endocrinology|August 6, 2014
Uncarboxylated osteocalcin stimulates 25-hydroxy vitamin D production in Leydig cell line through a GPRC6a-dependent pathwayLuca De Toni, Vincenzo De Filippis, Simone Tescari, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|February 17, 2021
Comparing the accuracy of transcutaneous sensor and 90-day implantable glucose sensorFederico Boscari, Martina Vettoretti, Anna Maria Letizia Amato, et al.
Journal of Diabetes and Its Complications|May 29, 2017
A decade-long telemedicine screening program for diabetic retinopathy in the north-east of ItalyStela Vujosevic, Porzia Pucci, Margherita Casciano, et al.
Diabetes Care|April 2, 2010
The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alphaGian Paolo Fadini, Elisa Boscaro, Mattia Albiero, et al.
Diabetes Care|February 13, 2010
Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetesGian Paolo Fadini, Elisa Boscaro, Saula de Kreutzenberg, et al.
Aging Clinical and Experimental Research|April 4, 2003
The fatty acid composition of plasma phospholipids and the insulin sensitivity in elderly diabetic patients. The Pro.V.A. studyEnzo Manzato, Giovanni Roselli della Rovere, Angelo Avogaro, et al.
Pageof 43